FDA Adverse Event Injury Summary report: N

ESPRIT¿

MDR report key: 23305135 · Received October 15, 2025

Report

Report Number
2024168-2025-11131
Event Type
Injury
Date Received
October 15, 2025
Date of Event
September 3, 2025
Report Date
October 15, 2025
Manufacturer
ABBOTT VASCULAR INC.
Product Code
NXW
UDI-DI
08717648357251
PMA / PMN Number
P230036
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
OH, US
Reporter Occupation
PHYSICIAN
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

THE DEVICE WAS NOT RETURNED FOR ANALYSIS. PRODUCTION RECORD AND CORRECTIVE AND PREVENTATIVE ACTIONS (CAPA) REVIEWS WERE PERFORMED AND REVEALED NO INDICATION OF A PRODUCT QUALITY ISSUE. ADDITIONALLY, A QUERY OF THE COMPLAINT HANDLING DATABASE FOR THE REPORTED LOT REVEALED THERE IS NO INDICATION OF A LOT SPECIFIC ISSUE. A CONCLUSIVE CAUSE FOR THE REPORTED PATIENT EFFECT, AND THE RELATIONSHIP TO THE PRODUCT, IF ANY, CANNOT BE DETERMINED. THE REPORTED PATIENT EFFECT(S) OF THROMBOSIS IS LISTED IN THE ESPRIT BTK EVEROLIMUS ELUTING RESORBABLE SCAFFOLD SYSTEMS INSTRUCTIONS FOR USE AS A KNOWN PATIENT EFFECT(S) OF CORONARY STENTING PROCEDURES. THERE IS NO INDICATION OF A PRODUCT QUALITY ISSUE WITH RESPECT TO MANUFACTURE, DESIGN OR LABELING.

Description of Event or Problem · 0

IT WAS REPORTED THAT THE PROCEDURE WAS PERFORMED ON (B)(6) 2025 TO TREAT A MILDLY CALCIFIED, MILDLY TORTUOUS LEFT ANTERIOR TIBIAL ARTERY. THE 2.50X38MM ESPRIT BTK RESORBABLE SCAFFOLD WAS IMPLANTED. IT WAS NOTED THAT DURING SCAFFOLD IMPLANTATION, POST-DILATION WAS NOT PERFORMED. ON (B)(6) 2025, THE PATIENT PRESENTED WITH PAIN IN THE LOWER LEFT LEG AND ANGIOGRAM REVEALED SCAFFOLD THROMBOSIS; HOWEVER, NO TREATMENT WAS GIVEN. NO ADDITIONAL INFORMATION WAS PROVIDED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
2289514 ESPRIT¿ SCAFFOLD,INFRAPOPLITEAL,ABSORBABLE NXW ABBOTT VASCULAR INC. 1203250-38 5022761 08717648357251

Patients

Seq Age Sex Outcome Treatment
1 NA Unknown Other